Ads
related to: Psoriatic Arthritis- See The Results
View Results From Clinical Trials
For Psoriatic Arthritis Symptoms.
- Types Of Doctors For PsA
See Which Types of Doctors
Can Help Treat Your PsA.
- What Is PsA?
Learn About Causes, Symptoms,
& Treatment Options.
- PsA Treatment
Talk With Your Doctor About
Available Treatments For PsA.
- Treatment Dosing Info
Get Information About The Dosing
Schedule For PsA Treatment.
- Find A Doctor
Find Doctors In Your Area
Using The Doctor Locator Tool.
- See The Results
Search results
Diagnosing Psoriatic Arthritis for the Dermatologist
Medscape· 2 days agoEditor's note: Drs Gottlieb and Merola refer to the following presentation throughout their discussion: Masterclasses in Dermatology™: Masterclass in ...
Guselkumab Provides Long-Term Relief From PsA Symptoms
Medscape· 2 days agoGuselkumab improved joint swelling, spinal pain, skin symptoms, and overall disease activity in a...
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 2 days agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to severe plaque psoriasis ...
Worldwide Prevalence of PsA: Meta-Analysis Sheds Light
Medscape· 7 days agoPsA is more prevalent in Europe and North America than in Asia and South America, according to a meta-analysis that assessed the worldwide PsA prevalence.
Stelara biosimilar from Alvotech, Teva approved by FDA
BioPharma Dive via Yahoo Finance· 2 days agoThe FDA cleared Selarsdi for treatment of moderate to severe plaque psoriasis and active psoriatic ...
Plaque psoriasis plagues Marietta man for over 30 years until new treatment
FOX 5 Atlanta· 3 days agoIt causes itchy, raised patches of skin that look and feel uncomfortable, but a Cobb County man...
FDA Approves Second Ustekinumab Biosimilar
Medscape· 2 days agoThe biosimilar is expected to be marketed in the United States on or after February 21, 2025.
Alvotech, Teva Get FDA Approval for Stelara Biosimilar Psoriasis Treatment
Morningstar· 2 days agoThe treatment is for patients with moderate to severe plaque psoriasis, adults with active psoriatic arthritis and pediatric patients six years and older ...
Rainsberger Wealth Advisors Inc. Decreases Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoRainsberger Wealth Advisors Inc. decreased its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 16.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 0.5%
ETF DAILY NEWS· 5 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report)’s stock price was down 0.5% during trading on Friday . Wells Fargo & Company decreased their price target on shares of Bristol-Myers Squibb ...
Ads
related to: Psoriatic Arthritis
